We work with policy-makers, clinicians, academia and industry to develop future-focused healthcare strategies for safe and suitable use of innovations, such as diagnostics, genome editing and regenerative medicines. Only through understanding the benefits - and complexities - of genomics-based innovations and other 'omics sciences can we help everyone benefit from great science.
Genomics into health
As genomic experts, we have a comprehensive understanding of how innovative technologies can contribute to more effective healthcare
BlogUsing whole genome sequencing to help combat COVID-19
The work of the COG-UK consortium will be crucial to mitigating the longer-term impacts of the COVID-19 outbreak….
BlogGenome editing: a broad perspective on a precision technology
Prime-editing is a one recent addition to the ever-growing suite of genome editing tools which could transform treatments for genetic diseases
Policy briefingSomatic genome editing: ethics and regulation
Enthusiasm for clinical genome editing must be tempered by regulatory oversight and underpinned by ethical debate
Policy briefingSomatic genome editing: promise and practicalities
Exploring the current and future uses of somatic genome editing for health
BlogA five-year strategy for infectious diseases
Dr Laura Blackburn welcomes PHE priority to optimise use of WGS-based information to tackle infectious diseases
BlogFrom theory to therapy in the genome editing boom
Genome editing has been riding the wave of hype for some time, but is genuinely making its way into healthcare
BlogPlans for paid-for NHS genome sequencing shelved
In a laudable policy decision to listen to concerns raised by the genomics community, plans for paying ‘genomic volunteers’ to receive NHS whole genome sequencing have been dropped.